Business Context and Reporting Period
This Form 6-K filing by Moolec Science SA covers the month of November 2025. The registrant is a Cayman Islands-based company with principal executive offices in Grand Cayman. The filing primarily addresses a regulatory compliance matter regarding the listing status of its ordinary shares on The Nasdaq Capital Market under the symbol "MLEC."
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure regarding listing compliance rather than a financial results statement.
Material Changes and Events
- Nasdaq Non-Compliance Notice: On November 14, 2025, the Company received a determination letter from Nasdaq stating that its closing bid price had been below the minimum $1.00 per share requirement for 30 consecutive business days (Nasdaq Listing Rule 5550(a)(2)).
- Appeal Filed: The Company submitted a timely appeal to a Nasdaq Hearings Panel to request a 180-day period to regain compliance.
- Trading Status: The appeal automatically stays the delisting effect. Shares will continue to trade on Nasdaq without interruption pending the hearing.
- Hearing Date: The appeal will be considered on December 18, 2025.
Outlook, Risks, and Management Commentary
Management intends to evaluate and execute appropriate actions to cure the deficiency, which may include a reverse stock split if deemed in the best interest of shareholders. The Company asserts that the receipt of the determination letter does not affect its business, operations, or SEC reporting requirements. The filing includes standard forward-looking statement disclaimers, noting that actual results may differ due to risks such as regulatory changes, economic factors, and scaling costs.
Investor Verification Checklist
- Verify the outcome of the Nasdaq Hearings Panel scheduled for December 18, 2025.
- Monitor the Company's announcement regarding the potential implementation of a reverse stock split.
- Review the Company's most recent Form 20-F for detailed financial data and risk factors not included in this 6-K.
- Track the daily closing bid price to assess ongoing compliance with the $1.00 minimum requirement.